Patients and the Public Deserve Big Changes in Evaluation of Drugs: Ending the Secrecy Surrounding Drug Trials Would Benefit All Parties
Keywords
DrugsEvaluation
Patients
Drugs and Drug Industry
Human Experimentation Policy Guidelines / Institutional Review Boards
Business Ethics
Full record
Show full item recordOnline Access
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Patients+and+the+public+deserve+big+changes+in+evaluation+of+drugs:+ending+the+secrecy+surrounding+drug+trials+would+benefit+all+parties&title=BMJ:+British+Medical+Journal+&volume=338&issue=7698&date=2009-04&au=Garattini,+Silvio;+Chalmers,+Iainhttps://dx.doi.org/10.1136/bmj.b1025
http://hdl.handle.net/10822/1028594
Date
2016-01-09Identifier
oai:repository.library.georgetown.edu:10822/1028594doi:10.1136/bmj.b1025
BMJ: British Medical Journal 2009 April 4; 338(7698): 804-806
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Patients+and+the+public+deserve+big+changes+in+evaluation+of+drugs:+ending+the+secrecy+surrounding+drug+trials+would+benefit+all+parties&title=BMJ:+British+Medical+Journal+&volume=338&issue=7698&date=2009-04&au=Garattini,+Silvio;+Chalmers,+Iain
http://dx.doi.org/10.1136/bmj.b1025
http://hdl.handle.net/10822/1028594
DOI
10.1136/bmj.b1025ae974a485f413a2113503eed53cd6c53
10.1136/bmj.b1025